Table 1 Baseline characteristics of patients with pressure ulcers based on the DESIGN-R category of depth
d2 | D3 | D4, 5 | DU | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compliance group (n = 154) | Non-compliance group (n = 189) | Absolute standardized difference, % | P value | Compliance group (n = 130) | Non-compliance group (n = 90) | Absolute standardized difference, % | P value | Compliance group (n = 104) | Non-compliance group (n = 55) | Absolute standardized difference, % | P value | Compliance group (n = 59) | Non-compliance group (n = 87) | Absolute standardized difference, % | P value | |
Age (years) | 82.4 ± 9.0 | 79.3 ± 11.6 | 29.9 | 0.06 | 81.1 ± 10.3 | 78.8 ± 12.9 | 19.7 | 0.137 | 80.5 ± 11.5 | 80.5 ± 10.8 | 0 | 0.988 | 79.2 ± 10.0 | 76.7 ± 14.7 | 19.9 | 0.265 |
Sex (male) (%) | 51.9 | 54.5 | 3.8 | 0.403 | 56.0 | 55.6 | 0.6 | 0.949 | 40.3 | 36.3 | 5.1 | 0.624 | 45.7 | 56.3 | 15.1 | 0.213 |
Hemoglobin (g/dL) | 10.9 ± 2.2 | 10.8 ± 2.3 | 4.4 | 0.529 | 10.5 ± 2.1 | 10.7 ± 1.9 | 10.0 | 0.57 | 9.9 ± 1.8 | 10.1 ± 1.7 | 11.4 | 0.606 | 9.9 ± 1.9 | 10.5 ± 2.1 | 29.9 | 0.107 |
Albumin (g/dL) | 2.9 ± 0.6 | 2.9 ± 0.8 | 0.0 | 0.808 | 2.6 ± 0.6 | 2.6 ± 0.6 | 0 | 0.38 | 2.6 ± 0.6 | 2.5 ± 0.7 | 15.3 | 0.727 | 2.6 ± 0.5 | 2.7 ± 0.6 | 18.1 | 0.25 |
DESIGN-R score at baseline | 9.4 ± 4.9 | 7.5 ± 4.8 | 39.1 | <0.001 | 15.4 ± 7.3 | 15.4 ± 7.0 | 0 | 0.969 | 28.0 ± 12.5 | 23.0 ± 7.3 | 48.9 | 0.007 | 24.6 ± 10.3 | 20.3 ± 10.3 | 41.7 | 0.014 |
Observational period (day) | 23.1 ± 20.1 | 26.1 ± 23.8 | 13.6 | 0.211 | 43.2 ± 42.1 | 57.3 ± 93.1 | 19.5 | 0.132 | 70.5 ± 55.6 | 68.8 ± 65.5 | 2.7 | 0.86 | 52.5 ± 59.7 | 57.3 ± 88.8 | 6.3 | 0.718 |
Locations | - | - | - | - | ||||||||||||
Sacrum | 55 | 87 | - | - | 43 | 38 | - | - | 56 | 28 | - | - | 16 | 32 | - | - |
Coccyx | 22 | 20 | - | - | 7 | 9 | - | - | 3 | 2 | - | - | 2 | 3 | - | - |
Greater trochanter | 17 | 13 | - | - | 20 | 8 | - | - | 8 | 4 | - | - | 7 | 13 | - | - |
Heel | 10 | 17 | - | - | 24 | 10 | - | - | 11 | 4 | - | - | 14 | 20 | - | - |
Ilium | 4 | 7 | - | - | 5 | 4 | - | - | 4 | 5 | - | - | 5 | 3 | - | - |
Others | 46 | 45 | - | - | 31 | 21 | - | - | 22 | 12 | - | - | 15 | 16 | - | - |